Top Markets
#1 Fabric Protocol Fabric Protocol +32.06%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.94%
#3 Tutorial Tutorial +31.67%
#4 Bitcoin Cash Bitcoin Cash +31.12%
#5 GALA GALA +30.99%
#6 Audiera Audiera +30.55%
#7 Zora Zora +26.33%
#8 GoPlus Security GoPlus Security +26.04%
#9 Arowana Arowana +25.32%
#10 Talus Network Talus Network +24.98%
Coin of the day
Fabric Protocol Fabric Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang in Aktien #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aktienkurs
$0.78611575
Marktkapitalisierung
$60.45M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Lytix Biopharma AS (LYTIX)
Dividendenrendite (TTM) von Lytix Biopharma AS (Aktienkürzel: LYTIX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Lytix Biopharma AS (LYTIX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH